Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 42.1% in November

Aethlon Medical, Inc. (NASDAQ:AEMD) saw a significant decline in short interest in November. As of November 30th, there was short interest totalling 203,400 shares, a decline of 42.1% from the November 15th total of 351,100 shares. Based on an average daily trading volume, of 615,200 shares, the short-interest ratio is currently 0.3 days.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the company. HC Wainwright restated a “buy” rating and set a $7.00 target price on shares of Aethlon Medical in a research report on Friday, November 15th. StockNews.com assumed coverage on Aethlon Medical in a report on Tuesday. They issued a “sell” rating on the stock.

Aethlon Medical Stock Performance

Shares of NASDAQ AEMD opened at $0.36 on Friday. The firm has a market cap of $5.01 million, a PE ratio of -0.13 and a beta of 1.79. Aethlon Medical has a one year low of $0.24 and a one year high of $2.35. The firm has a fifty day moving average of $0.39 and a 200 day moving average of $0.42.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.